Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIA: Benralizumab in mild atopic asthma
NCT02821416Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2016
- Primary completion
- Oct 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Oct 2016; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02821416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821416.